R&D Tax Credits and Deductions Explained

The research and development (R&D) tax credit is one of the most significant domestic tax credits remaining under current tax law. Savvy corporate tax teams can use this important tool to implement federal tax planning strategies that maximize their company’s value.

But the tax issues around R&D investment and acquisitions are complex and, like many other aspects of corporate tax planning, require forethought and a deep understanding of recent changes – such as the section 174 amortization triggered in 2022 by the Tax Cuts and Jobs Act (TCJA). Tax professionals must stay up to date on developments to guide the right tax-optimized decisions, both now and in the future.

Read on to gain timely and valuable insight into the R&D tax credit, including eligibility, deductions, R&D credit limitation, amortization, and more. We’ve also outlined the recently introduced American Innovation and R&D Competitiveness Act of 2025, a bipartisan bill put forth by congressional lawmakers to help businesses deduct research and development expenses in the tax year that they occur.

[Download our R&D Notice 2023-63 Overview for guidance on the capitalization and amortization of specified research or experimental expenditures under IRC 174.]

Bloomberg Tax Analyst Benjamin Rubelmann breaks down the new R&D amortization rules and how some research expenses may still qualify for immediate tax credit under §41.

American Innovation and R&D Competitiveness Act of 2025

The amortization mandate resulted in higher tax bills and higher compliance costs for businesses across the country. As a result, American innovation and competitiveness on the international stage has decreased. After previously growing more than 6.5% annually, R&D spending in the U.S. increased only 3.5% over the course of 2022 and decreased in 2023.

In response, a bipartisan group of U.S. lawmakers reintroduced the American Innovation and R&D Competitiveness Act of 2025, a bill that mirrors previously introduced legislation. It aims to amend the 1986 IRC code to reinstate immediate R&D expensing so that businesses can deduct research and development expenses in the tax year that they occur.

According to the National Association of Manufacturers (NAM), a return to immediate expensing would drive job creation: 75% of companies’ R&D spending goes to workers’ salaries. A recent report published by NAM shows that for every $1 billion spent on R&D, 17,000 American jobs are supported.

Passage of the 2025 act would reduce the tax and compliance burden on businesses, incentivize greater investment in research and technological advancements, and ensure that the U.S. remains competitive with other nations that offer more favorable R&D tax treatments.

Watch a clip from a recent webinar to see how to use Bloomberg Tax Workpapers to streamline and simplify your process for calculating an R&D credit amount. (6:00)

[Download our R&D Notice 2023-63 Overview for guidance on the capitalization and amortization of specified research or experimental expenditures under IRC 174.]

Recommended for you

Discover the new generation Bloomberg Tax suite

Our suite of integrated solutions automates tedious work, minimizes risk, and frees up time to do more strategic work.